应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02192 医脉通
休市中 08-23 16:08:27
7.180
-0.240
-3.23%
最高
7.420
最低
7.180
成交量
18.25万
今开
7.420
昨收
7.420
日振幅
3.23%
总市值
52.62亿
流通市值
52.62亿
总股本
7.33亿
成交额
132.79万
换手率
0.02%
流通股本
7.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩
格隆汇 · 08-08
医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩
医脉通早盘涨逾13% 近日与NCCN达成癌症护理战略合作
新浪港股 · 08-06
医脉通早盘涨逾13% 近日与NCCN达成癌症护理战略合作
异动解读 | 医脉通与美国NCCN达成合作 股价大涨16.55%
异动解读 · 08-06
异动解读 | 医脉通与美国NCCN达成合作 股价大涨16.55%
【港股异动 | 医脉通(02192.HK)盘中涨超17% 近日与NCCN达成癌症护理战略合作】智通财经APP获悉,医脉通(02192.
智通财经 · 08-06
【港股异动 | 医脉通(02192.HK)盘中涨超17% 近日与NCCN达成癌症护理战略合作】智通财经APP获悉,医脉通(02192.
港股异动 | 医脉通(02192)盘中涨超17% 近日与NCCN达成癌症护理战略合作
智通财经 · 08-06
港股异动 | 医脉通(02192)盘中涨超17% 近日与NCCN达成癌症护理战略合作
医脉通(02192)股价大幅波动20.43%,现价港币$6.81
阿斯达克财经 · 08-05
医脉通(02192)股价大幅波动20.43%,现价港币$6.81
异动解读 | 医脉通盘中大涨11.96% 业绩表现亮眼或是主因
异动解读 · 08-05
异动解读 | 医脉通盘中大涨11.96% 业绩表现亮眼或是主因
医脉通(02192)上涨5.51%,报7.85元/股
金融界 · 08-05
医脉通(02192)上涨5.51%,报7.85元/股
医脉通盘中异动 下午盘急速拉升5.50%报7.850港元
自选股智能写手 · 08-05
医脉通盘中异动 下午盘急速拉升5.50%报7.850港元
医脉通(02192)股价上升5.511%,现价港币$7.85
阿斯达克财经 · 08-05
医脉通(02192)股价上升5.511%,现价港币$7.85
医脉通(02192.HK)与NCCN达成癌症护理战略合作
阿斯达克财经 · 07-30
医脉通(02192.HK)与NCCN达成癌症护理战略合作
医脉通(02192)下跌5.03%,报7.37元/股
金融界 · 07-30
医脉通(02192)下跌5.03%,报7.37元/股
医脉通根据获采纳首次公开发售前购股权计划发行130.95万股
新浪港股 · 07-29
医脉通根据获采纳首次公开发售前购股权计划发行130.95万股
医脉通(02192)根据获采纳首次公开发售前购股权计划发行130.95万股
智通财经 · 07-26
医脉通(02192)根据获采纳首次公开发售前购股权计划发行130.95万股
【医脉通(02192.HK)根据获采纳首次公开发售前购股权计划发行130.95万股】智通财经APP讯,医脉通(02192.
智通财经 · 07-26
【医脉通(02192.HK)根据获采纳首次公开发售前购股权计划发行130.95万股】智通财经APP讯,医脉通(02192.
医脉通因购股权获行使发行合计88.75万股
新浪港股 · 07-26
医脉通因购股权获行使发行合计88.75万股
医脉通(02192)因购股权获行使发行合计88.75万股
智通财经网 · 07-26
医脉通(02192)因购股权获行使发行合计88.75万股
【医脉通(02192.HK)因购股权获行使发行合计88.75万股】智通财经APP讯,医脉通(02192.HK)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月23日发行18.
智通财经 · 07-26
【医脉通(02192.HK)因购股权获行使发行合计88.75万股】智通财经APP讯,医脉通(02192.HK)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月23日发行18.
医脉通盘中异动 早盘快速下跌6.47%
自选股智能写手 · 07-23
医脉通盘中异动 早盘快速下跌6.47%
医脉通因购股权获行使发行合计237.3万股
新浪港股 · 07-23
医脉通因购股权获行使发行合计237.3万股
公司概况
公司名称:
医脉通
所属市场:
SEHK
上市日期:
--
主营业务:
医脉通科技有限公司是一家主要运营在线专业医师平台的中国投资控股公司。该公司运营三个业务部门。精准营销及企业解决方案部门包括精准营销解决方案及企业解决方案。其中精准营销解决方案包括数字推送、营销咨询以及内容创建服务。企业解决方案的收益主要是软件即服务(SaaS)。医学知识解决方案部门主要提供专业医学信息和医疗软件服务。智能患者管理解决方案部门主要提供线上患者咨询及处方服务和患者管理服务。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02192","market":"HK","secType":"STK","nameCN":"医脉通","latestPrice":7.18,"timestamp":1724400507029,"preClose":7.42,"halted":0,"volume":182500,"delay":0,"floatShares":732851000,"shares":732851000,"eps":0.36780104,"marketStatus":"休市中","marketStatusCode":7,"change":-0.24,"latestTime":"08-23 16:08:27","open":7.42,"high":7.42,"low":7.18,"amount":1327935,"amplitude":0.032345,"askPrice":7.2,"askSize":1000,"bidPrice":7.18,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.36151317683197814,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1626278400000,"adjPreClose":7.42,"dividendRate":0.035332,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":0.6850600602914992,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02192/wiki","defaultTab":"wiki","newsList":[{"id":"2457366560","title":"医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2457366560","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457366560?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:52","pubTimestamp":1723107178,"startTime":"0","endTime":"0","summary":"格隆汇8月8日丨医脉通(02192.HK)宣布,公司将于2024年8月27日(星期二)举行董事会会议,藉以(其中包括)考虑及批准公司及其附属公司截至2024年6月30日止六个月的中期业绩,并考虑派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808165258af9692cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808165258af9692cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02192","BK1587"],"gpt_icon":0},{"id":"2457052261","title":"医脉通早盘涨逾13% 近日与NCCN达成癌症护理战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2457052261","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457052261?lang=zh_cn&edition=full","pubTime":"2024-08-06 11:52","pubTimestamp":1722916321,"startTime":"0","endTime":"0","summary":"医脉通(02192)盘中曾涨超17%,涨幅现收窄,股价上涨12.63%,报7.76港元,成交额1204.75万港元。\n 美国国家综合癌症网络(NCCN)近日与医脉通宣布达成战略合作,双方将扩大中国著名肿瘤学指南的可及性,为中国医疗专业人员及病人提供癌症护理所需的关键资源。\n 据悉,截至今年6月,NCCN拥有超过190万名注册用户,按地区划分,中国是用户数第二大的国家,仅次于美国,癌症相关护理指引每年下载量超过85万次,当中不少用户透过医脉通平台进行下载。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-06/doc-inchsmtm7007984.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-06/doc-inchsmtm7007984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"1174996164","title":"异动解读 | 医脉通与美国NCCN达成合作 股价大涨16.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174996164","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174996164?lang=zh_cn&edition=full","pubTime":"2024-08-06 11:40","pubTimestamp":1722915650,"startTime":"0","endTime":"0","summary":"医脉通今日盘中股价大涨16.55%,报收7.59港元,成交额1136.99万港元。股价大涨引发市场广泛关注。消息面上,医脉通近日与美国国家综合癌症网络达成战略合作,双方将扩大中国著名肿瘤学指南的可及性,为中国医疗专业人员及病人提供癌症护理所需的关键资源。医脉通作为国内领先的医疗健康服务平台,与NCCN的合作将有助于公司拓展癌症护理业务,提高在肿瘤学领域的专业地位,从而获得更多用户和收入。市场对此前景表示看好,推动公司股价大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"gpt_icon":0},{"id":"2457549850","title":"【港股异动 | 医脉通(02192.HK)盘中涨超17% 近日与NCCN达成癌症护理战略合作】智通财经APP获悉,医脉通(02192.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457549850","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457549850?lang=zh_cn&edition=full","pubTime":"2024-08-06 11:35","pubTimestamp":1722915302,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"2457054986","title":"港股异动 | 医脉通(02192)盘中涨超17% 近日与NCCN达成癌症护理战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2457054986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457054986?lang=zh_cn&edition=full","pubTime":"2024-08-06 11:35","pubTimestamp":1722915302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医脉通(02192)盘中涨超17%,截至发稿,涨10.16%,报7.59港元,成交额1136.99万港元。消息面上,美国国家综合癌症网络(NCCN)近日与医脉通宣布达成战略合作,双方将扩大中国著名肿瘤学指南的可及性,为中国医疗专业人员及病人提供癌症护理所需的关键资源。据悉,截至今年6月,NCCN拥有超过190万名注册用户,按地区划分,中国是用户数第二大的国家,仅次于美国,癌症相关护理指引每年下载量超过85万次,当中不少用户透过医脉通平台进行下载。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2457532715","title":"医脉通(02192)股价大幅波动20.43%,现价港币$6.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2457532715","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457532715?lang=zh_cn&edition=full","pubTime":"2024-08-05 14:10","pubTimestamp":1722838200,"startTime":"0","endTime":"0","summary":"[异动股]医脉通(02192) 股价在下午02:10出现大幅波动20.43%,现股价为港币$6.81,比前收市价下跌8.468%。至目前为止,今日最高价为$8.33,而最低价为$6.81。总成交量为365.1万股,总成交金额为港币$2.746千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112134428668_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112134428668_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC240805275/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1587","BK1189","02192"],"gpt_icon":0},{"id":"1150441824","title":"异动解读 | 医脉通盘中大涨11.96% 业绩表现亮眼或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1150441824","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150441824?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:26","pubTimestamp":1722835583,"startTime":"0","endTime":"0","summary":"医脉通(02192)今日盘中大涨11.96%,引发市场关注。根据新闻报道,该公司最新财报数据显示,2023年营业收入达4.55亿港元,净利润2.67亿港元,每股收益0.37港元,业绩表现亮眼。\n\n作为一家专注于医疗信息服务和数字营销的公司,医脉通拥有超过300万注册医生的在线平台,为医药企业提供精准营销解决方案。公司的主要业务包括精准营销及企业解决方案、医学知识解决方案以及智能患者管理解决方案等。\n\n分析人士认为,医脉通良好的业绩表现可能是推动股价大涨的主要原因。公司在医疗信息服务和数字营销领域的领先地位,以及持续增长的业务规模和盈利能力,增强了投资者对其长期发展前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"gpt_icon":0},{"id":"2457183792","title":"医脉通(02192)上涨5.51%,报7.85元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457183792","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457183792?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:14","pubTimestamp":1722834866,"startTime":"0","endTime":"0","summary":"8月5日,医脉通(02192)盘中上涨5.51%,截至13:14,报7.85元/股,成交738.77万元。医脉通科技有限公司主要业务是开发医药学工具软件,包括《全医药学大词典》、《临床用药参考》、《医学文献王》等,并创建了拥有超过300万注册医生的《医脉通》平台。此外,公司还为药企提供精准、高效的数字营销服务,已发展成为专业的医学信息服务及精准数字营销服务提供商。截至2023年年报,医脉通营业总收入4.12亿元、净利润2.42亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/05131442042714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2457920517","title":"医脉通盘中异动 下午盘急速拉升5.50%报7.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457920517","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457920517?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:14","pubTimestamp":1722834865,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘13时14分,医脉通股票出现波动,股价快速上涨5.50%。截至发稿,该股报7.850港元/股,成交量98.75万股,换手率0.13%,振幅8.87%。资金方面,该股资金流入517.145万港元,流出182.874万港元。医脉通股票所在的医疗及医学美容服务行业中,整体跌幅为1.51%。其相关个股中,梅斯健康、医脉通、海吉亚医疗涨幅较大,振幅较大的相关个股有梅斯健康、美中嘉和、现代健康科技,振幅分别为36.36%、19.63%、13.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080513142696823a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080513142696823a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2457879766","title":"医脉通(02192)股价上升5.511%,现价港币$7.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2457879766","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457879766?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:14","pubTimestamp":1722834840,"startTime":"0","endTime":"0","summary":"[上升股]医脉通(02192) 股价在下午01:14比前收市价上升5.511%,现股价为港币$7.85。至目前为止,今日最高价为$7.85,而最低价为$7.19。总成交量为98.75万股,总成交金额为港币$738.772万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408051908/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1189","02192","BK1587"],"gpt_icon":0},{"id":"2455339677","title":"医脉通(02192.HK)与NCCN达成癌症护理战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2455339677","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455339677?lang=zh_cn&edition=full","pubTime":"2024-07-30 14:23","pubTimestamp":1722320580,"startTime":"0","endTime":"0","summary":"美国国家综合癌症网络(NCCN)与医脉通(02192.HK) 宣布达成战略合作,双方将扩大中国著名肿瘤学指南的可及性,为中国医疗专业人员及病人提供癌症护理所需的关键资源。截至今年6月,NCCN拥有超过190万名注册用户,按地区划分,中国是用户数第二大的国家,仅次于美国,癌症相关护理指引每年下载量超过85万次,当中不少用户透过医脉通平台进行下载。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-30 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220225103357081_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220225103357081_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1367426/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1189","02192","BK1587"],"gpt_icon":0},{"id":"2455767952","title":"医脉通(02192)下跌5.03%,报7.37元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455767952","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455767952?lang=zh_cn&edition=full","pubTime":"2024-07-30 13:20","pubTimestamp":1722316846,"startTime":"0","endTime":"0","summary":"7月30日,医脉通(02192)盘中下跌5.03%,截至13:20,报7.37元/股,成交153.08万元。医脉通科技有限公司主要业务是开发医药学工具软件,包括《全医药学大词典》、《临床用药参考》、《医学文献王》等,并创建了拥有超过300万注册医生的《医脉通》平台。此外,公司还为药企提供精准、高效的数字营销服务,已发展成为专业的医学信息服务及精准数字营销服务提供商。截至2023年年报,医脉通营业总收入4.12亿元、净利润2.42亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/30132041896443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2455572359","title":"医脉通根据获采纳首次公开发售前购股权计划发行130.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455572359","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455572359?lang=zh_cn&edition=full","pubTime":"2024-07-29 08:53","pubTimestamp":1722214425,"startTime":"0","endTime":"0","summary":"医脉通(02192)发布公告,于2024年7月26日根据获采纳首次公开发售前购股权计划发行130.95万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-29/doc-incfuerk9286500.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-29/doc-incfuerk9286500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2454463973","title":"医脉通(02192)根据获采纳首次公开发售前购股权计划发行130.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2454463973","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454463973?lang=zh_cn&edition=full","pubTime":"2024-07-26 20:10","pubTimestamp":1721995855,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医脉通(02192)发布公告,于2024年7月26日根据获采纳首次公开发售前购股权计划发行130.95万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02192","BK1189","BK1587"],"gpt_icon":0},{"id":"2454234637","title":"【医脉通(02192.HK)根据获采纳首次公开发售前购股权计划发行130.95万股】智通财经APP讯,医脉通(02192.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454234637","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454234637?lang=zh_cn&edition=full","pubTime":"2024-07-26 20:10","pubTimestamp":1721995855,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02192","BK1189","BK1587"],"gpt_icon":0},{"id":"2454334324","title":"医脉通因购股权获行使发行合计88.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2454334324","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454334324?lang=zh_cn&edition=full","pubTime":"2024-07-26 07:38","pubTimestamp":1721950711,"startTime":"0","endTime":"0","summary":"医脉通(02192)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月23日发行18.75万股。\n 根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司两位董事于2024年7月25日发行70万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-26/doc-incfmiek2229604.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-26/doc-incfmiek2229604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2454408335","title":"医脉通(02192)因购股权获行使发行合计88.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2454408335","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454408335?lang=zh_cn&edition=full","pubTime":"2024-07-26 06:16","pubTimestamp":1721945819,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医脉通(02192)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月23日发行18.75万股。根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司两位董事于2024年7月25日发行70万股。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1189","02192","BK1587"],"gpt_icon":0},{"id":"2454335230","title":"【医脉通(02192.HK)因购股权获行使发行合计88.75万股】智通财经APP讯,医脉通(02192.HK)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月23日发行18.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454335230","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454335230?lang=zh_cn&edition=full","pubTime":"2024-07-26 06:16","pubTimestamp":1721945819,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","02192","BK1189"],"gpt_icon":0},{"id":"2453722994","title":"医脉通盘中异动 早盘快速下跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453722994","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453722994?lang=zh_cn&edition=full","pubTime":"2024-07-23 10:03","pubTimestamp":1721700228,"startTime":"0","endTime":"0","summary":"2024年07月23日早盘10时03分,医脉通股票出现异动,股价急速下挫6.47%。截至发稿,该股报7.530港元/股,成交量500股,换手率0.00%,振幅0.00%。医脉通股票所在的医疗及医学美容服务行业中,整体跌幅为0.60%。其相关个股中,康宁医院、清晰医疗、完美医疗涨幅较大,振幅较大的相关个股有美中嘉和、海吉亚医疗、康宁医院,振幅分别为8.01%、5.27%、4.49%。医脉通公司简介:医脉通科技有限公司是一家主要运营在线专业医师平台的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723100348941f95e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723100348941f95e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1189","02192"],"gpt_icon":0},{"id":"2453742384","title":"医脉通因购股权获行使发行合计237.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453742384","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453742384?lang=zh_cn&edition=full","pubTime":"2024-07-23 07:02","pubTimestamp":1721689359,"startTime":"0","endTime":"0","summary":"医脉通(02192)发布公告,根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司员工于2024年7月22日发行57.3万股。\n 根据公司于2021年3月29日采纳的首次公开发售前购股权计划向行使购股权的公司3位董事于2024年7月22日发行180万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-23/doc-incfamtm0598199.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-23/doc-incfamtm0598199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1189","BK1587","02192"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0747},{"period":"1month","weight":-0.0911},{"period":"3month","weight":-0.059},{"period":"6month","weight":-0.0336},{"period":"1year","weight":0.1372},{"period":"ytd","weight":-0.1533}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医脉通科技有限公司是一家主要运营在线专业医师平台的中国投资控股公司。该公司运营三个业务部门。精准营销及企业解决方案部门包括精准营销解决方案及企业解决方案。其中精准营销解决方案包括数字推送、营销咨询以及内容创建服务。企业解决方案的收益主要是软件即服务(SaaS)。医学知识解决方案部门主要提供专业医学信息和医疗软件服务。智能患者管理解决方案部门主要提供线上患者咨询及处方服务和患者管理服务。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.179583},{"month":2,"riseRate":0.333333,"avgChangeRate":0.000679},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.055193},{"month":4,"riseRate":0.666667,"avgChangeRate":0.025989},{"month":5,"riseRate":0,"avgChangeRate":-0.11026},{"month":6,"riseRate":0.666667,"avgChangeRate":0.100202},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062441},{"month":8,"riseRate":0.75,"avgChangeRate":0.087531},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.002623},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.062041},{"month":11,"riseRate":0.666667,"avgChangeRate":0.228676},{"month":12,"riseRate":0,"avgChangeRate":-0.190084}],"exchange":"SEHK","name":"医脉通","nameEN":"MEDLIVE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医脉通,02192,医脉通股票,医脉通股票老虎,医脉通股票老虎国际,医脉通行情,医脉通股票行情,医脉通股价,医脉通股市,医脉通股票价格,医脉通股票交易,医脉通股票购买,医脉通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}